A $2B delay — What ASCs, hospitals are missing out on when shutting down joint replacement programs

It’s believed that COVID-19-related elective surgery cancellations at hospitals and ASCs cost both facilities around $5 billion in lost revenue, a Kaiser Health News analysis published in Fortune concludes.

Advertisement

What you should know:

1. U.S. hospitals collect an annual market value between $15.5 billion and $21.5 billion for knee replacements. Hip replacements, which make up about half the volume of knee replacements, increase the total annual value to between $23 billion and $32 billion.

2. For every month a hospital or ASC shut down their knee replacement program, they lose between $1.3 billion and $1.8 billion; adding in hip replacements increases that figure to between $1.9 billion and $2.7 billion.

3. Hip and knee replacement rates more than doubled from 2000 to 2015, and with knee replacement rates expected to triple between 2020 and 2040.

More articles on specialty care:
ASC considers in-house alternative to ‘overwhelmed’ hospital testing center — 3 insights
425 surgery centers that received PPP funds of more than $150K by state
4 COVID-19 testing insights for ASCs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedics / TJR

Advertisement

Comments are closed.